J C Reubi
16.02.2010
Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial
Cordier D, Reubi J, Mäcke H, Müller-Brand J, Good S, Apostolidis C, Morgenstern A, Bruchertseifer F, Forrer F, Merlo A. Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial. Eur J Nucl Med Mol Imaging 2010; 37:1335-44.
16.02.2010Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial
16.02.2010Eur J Nucl Med Mol Imaging 2010; 37:1335-44
Cordier D, Reubi J C, Mäcke H, Müller-Brand J, Good S, Apostolidis C, Morgenstern A, Bruchertseifer F, Forrer Flavio, Merlo A
Weiter
01.12.2007
Up-regulation of somatostatin receptor density on rat CA20948 tumors escaped from low dose [177Lu-DOTA0,Tyr3]octreotate therapy
Melis M, Forrer F, Capello A, Bijster M, Bernard B, Reubi J, Krenning E, de Jong M. Up-regulation of somatostatin receptor density on rat CA20948 tumors escaped from low dose [177Lu-DOTA0,Tyr3]octreotate therapy. Q J Nucl Med Mol Imaging 2007; 51:324-33.
01.12.2007Up-regulation of somatostatin receptor density on rat CA20948 tumors escaped from low dose [177Lu-DOTA0,Tyr3]octreotate therapy
01.12.2007Q J Nucl Med Mol Imaging 2007; 51:324-33
Melis M, Forrer Flavio, Capello A, Bijster M, Bernard B F, Reubi J C, Krenning E P, de Jong M
Weiter